Garnet Biotherapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2000-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery
Phase 2
Completed
- Conditions
- Scar Formation
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2013-10-24
- Lead Sponsor
- Garnet BioTherapeutics, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT01053897
- Locations
- 🇺🇸
Garnet BioTherapeutics Investigational Site, Rochester, New York, United States
News
No news found